Dodge & Cox Comments on Sanofi

Guru stock highlight

Author's Avatar
Sydnee Gatewood
Feb 04, 2021
Article's Main Image

Sanofi (

SNY, Financial) is a French pharmaceutical company with particular expertise in rare diseases. In recent years the company has rebuilt its management team, replacing its Chief Executive Officer, Chief Financial Officer, and Head of Research and Development with executives that have a demonstrable track record of success. Moreover, while the company's new drug pipeline shows promise, we believe the stock price only reflects the discounted value of the current portfolio of approved drugs, with little or no value ascribed to the new drug pipeline.

From Dodge & Cox's Global Stock Fund annual 2020 shareholder letter.

Also check out:
0 / 5 (0 votes)

Please Login to leave a comment

Please Login to leave a comment

Author's Avatar
I am the editorial director at GuruFocus. I have a BA in journalism and a MA in mass communications from Texas Tech University. I have lived in Texas most of my life, but also have roots in New Mexico and Colorado. Follow me on Twitter! @gurusydneerg